What Lilly is doing with its advertising campaign is taking the highest dose of its medicine and comparing it to a lower dose of the Novo medicine and then it is deceiving the people who see these campaigns into believing that the Lilly drug is greatly superior to the Novo drug. So it's it's not terribly complicated. They're using an old outdated study that that is a head-to-head study which is no longer current.And if they were using current data, it paints a very different picture. What we will show first ...